167 related articles for article (PubMed ID: 18519769)
1. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Saramäki OR; Harjula AE; Martikainen PM; Vessella RL; Tammela TL; Visakorpi T
Clin Cancer Res; 2008 Jun; 14(11):3395-400. PubMed ID: 18519769
[TBL] [Abstract][Full Text] [Related]
2. ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.
Scheble VJ; Braun M; Beroukhim R; Mermel CH; Ruiz C; Wilbertz T; Stiedl AC; Petersen K; Reischl M; Kuefer R; Schilling D; Fend F; Kristiansen G; Meyerson M; Rubin MA; Bubendorf L; Perner S
Mod Pathol; 2010 Aug; 23(8):1061-7. PubMed ID: 20473283
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.
Luedeke M; Rinckleb AE; FitzGerald LM; Geybels MS; Schleutker J; Eeles RA; Teixeira MR; Cannon-Albright L; Ostrander EA; Weikert S; Herkommer K; Wahlfors T; Visakorpi T; Leinonen KA; Tammela TLJ; Cooper CS; Kote-Jarai Z; Edwards S; Goh CL; McCarthy F; Parker C; Flohr P; Paulo P; Jerónimo C; Henrique R; Krause H; Wach S; Lieb V; Rau TT; Vogel W; Kuefer R; Hofer MD; Perner S; Rubin MA; Agarwal AM; Easton DF; Al Olama AA; Benlloch S; ; Hoegel J; Stanford JL; Maier C
Hum Mol Genet; 2016 Dec; 25(24):5490-5499. PubMed ID: 27798103
[TBL] [Abstract][Full Text] [Related]
4. Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-ERG (fusion)-driven prostate carcinogenesis.
Prasad RR; Mishra N; Kant R; Fox JT; Shoemaker RH; Agarwal C; Raina K; Agarwal R
Mol Carcinog; 2024 Jun; 63(6):1188-1204. PubMed ID: 38506376
[TBL] [Abstract][Full Text] [Related]
5. Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
Yin L; Rao P; Elson P; Wang J; Ittmann M; Heston WD
PLoS One; 2011; 6(6):e21319. PubMed ID: 21731703
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.
Mancarella C; Casanova-Salas I; Calatrava A; García-Flores M; Garofalo C; Grilli A; Rubio-Briones J; Scotlandi K; López-Guerrero JA
BMC Cancer; 2017 May; 17(1):367. PubMed ID: 28545426
[TBL] [Abstract][Full Text] [Related]
7. The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.
Xiao L; Lanz RB; Frolov A; Castro PD; Zhang Z; Dong B; Xue W; Jung SY; Lydon JP; Edwards DP; Mancini MA; Feng Q; Ittmann MM; He B
Prostate; 2016 Oct; 76(14):1271-84. PubMed ID: 27272765
[TBL] [Abstract][Full Text] [Related]
8. Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation-Mass Spectrometry Assays.
Fu Z; Rais Y; Bismar TA; Hyndman ME; Le XC; Drabovich AP
Mol Cell Proteomics; 2021; 20():100075. PubMed ID: 33771697
[TBL] [Abstract][Full Text] [Related]
9. PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer.
Warli SM; Warli MH; Prapiska FF
Res Rep Urol; 2023; 15():149-155. PubMed ID: 37181497
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel somatic fusions of
Liu Q; Wang S; Wang Z; Tang P; Zhang D; Lan W; Jiang J
Cancer Innov; 2022 Jun; 1(1):114-118. PubMed ID: 38089454
[TBL] [Abstract][Full Text] [Related]
11. Impact TMPRSS2-ERG Molecular Subtype on Prostate Cancer Recurrence.
Kobelyatskaya AA; Pudova EA; Snezhkina AV; Fedorova MS; Pavlov VS; Guvatova ZG; Savvateeva MV; Melnikova NV; Dmitriev AA; Trofimov DY; Sukhikh GT; Nyushko KM; Alekseev BY; Razin SV; Krasnov GS; Kudryavtseva AV
Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34205581
[TBL] [Abstract][Full Text] [Related]
12. Club-like cells in proliferative inflammatory atrophy of the prostate.
Huang FW; Song H; Weinstein HN; Xie J; Cooperberg MR; Hicks J; Mummert L; De Marzo AM; Sfanos KS
J Pathol; 2023 Sep; 261(1):85-95. PubMed ID: 37550827
[TBL] [Abstract][Full Text] [Related]
13. Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.
Challapalli A; Trousil S; Hazell S; Kozlowski K; Gudi M; Aboagye EO; Mangar S
J Clin Pathol; 2015 Sep; 68(9):703-9. PubMed ID: 26041862
[TBL] [Abstract][Full Text] [Related]
14. Handheld ISFET Lab-on-Chip detection of TMPRSS2-ERG and AR mRNA for prostate cancer prognostics.
Broomfield J; Kalofonou M; Franklin S; Powell SM; Pataillot-Meakin T; Moser N; Bevan CL; Georgiou P
IEEE Sens Lett; 2023 Aug; 7(8):1-4. PubMed ID: 37529707
[TBL] [Abstract][Full Text] [Related]
15. ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.
Feng W; Ladewig E; Salsabeel N; Zhao H; Lee YS; Gopalan A; Lange M; Luo H; Kang W; Fan N; Rosiek E; de Stanchina E; Chen Y; Carver BS; Leslie CS; Sawyers CL
bioRxiv; 2024 Apr; ():. PubMed ID: 38585869
[TBL] [Abstract][Full Text] [Related]
16. The role of T2E mediated CBF-1/RBP-Jκ signaling in metastatic thyroid cancer.
Hu A; Cao FF; Lu D; Yang LY
Am J Transl Res; 2021; 13(7):7610-7621. PubMed ID: 34377238
[TBL] [Abstract][Full Text] [Related]
17. Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL.
Brawer MK; Makarov DV; Partin AW; Roehrborn CG; Nickel JC; Lu SH; Yoshimura N; Chancellor MB; Assimos DG
Rev Urol; 2008; 10(2):136-56. PubMed ID: 18660856
[No Abstract] [Full Text] [Related]
18. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Graff RE; Pettersson A; Lis RT; DuPre N; Jordahl KM; Nuttall E; Rider JR; Fiorentino M; Sesso HD; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Nguyen PL; Sweeney CJ; Mucci LA;
Prostate; 2015 Jun; 75(9):897-906. PubMed ID: 25728532
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
